CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

CADTH Procedures for Drug Reimbursement Reviews

In order to ensure a smooth and efficient process, it is important that sponsors pay careful attention to CADTH documentation. As documentation posted to the CADTH website is subject to change, please access this content as it is needed instead of downloading and archiving it.

Procedures

The Procedures for CADTH Drug Reimbursement Reviews details the procedures to be followed by all participants involved in a drug reimbursement review, and provides guidance to sponsors in the preparation of their applications. This document must be read in conjunction with any CADTH Pharmaceutical Reviews Update issued after the procedures’ date of publication. CADTH has a fee structure that applies to its drug reimbursement review processes, please consult the Fee Schedule for CADTH Pharmaceutical Reviews for complete details. 

Note: For ongoing files that are being reviewed through the previous CADTH Common Drug Review (CDR) and CADTH pan-Canadian Oncology Drug Review (pCODR) processes, the procedure documents and templates listed below are applicable:
 

CADTH CDR applications received prior to October 26, 2020

CADTH pCODR applications received prior to October 20, 2020

Templates

The following templates are to be used by sponsors in accordance with the requirements outlined in the Procedures for CADTH Drug Reimbursement Reviews.

Templates for Pre-submission Phase

Templates for Requirements

Templates for Stakeholder Input